New study explores hidden metabolic differences between lipedema and obesity
NCT ID NCT07240298
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 140 women to compare metabolic risk markers—like insulin resistance and cholesterol ratios—between those with lipedema and those with obesity. Researchers used existing blood test results to calculate these markers without any new treatments or interventions. The goal is to better understand how lipedema affects metabolic health compared to regular obesity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study finds clear differences, it could help doctors better distinguish lipedema from obesity and guide future research on metabolic risks.
- What could go wrong
- This is a small, completed observational study using existing data, so it cannot prove cause and effect. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?